I called ITOR/GHS and Oncolix had tested Prolanta initially on a lot more than 3 patients. They only had enough of the drug to complete 3 patients. Those 15 that are lined up are probably the ones who they weren't able to get enough of the drug for.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.